Literature DB >> 17017558

Deep brain stimulation for the treatment of Parkinson's disease.

C Hamani1, J Neimat, A M Lozano.   

Abstract

Approximately 30,000 patients have been treated throughout the world with deep brain stimulation for Parkinson's disease and other conditions. With accumulating experience, there has been an appreciation of the important benefits of this procedure, including the alleviation of disability and improvement in the quality of life. We have also become aware of some limitations of DBS surgery. Among the important issues that remain to be resolved are the timing of surgery, whether early or late in the course of the disease, and the best target for the individual patient, including a reassessment of the relative merits of globus pallidus versus subthalamic nucleus surgery. A better understanding of the symptoms that are resistant to both levodopa therapy and DBS surgery is also required.

Entities:  

Mesh:

Year:  2006        PMID: 17017558     DOI: 10.1007/978-3-211-45295-0_59

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  10 in total

Review 1.  Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.

Authors:  Antonio Alcaro; Robert Huber; Jaak Panksepp
Journal:  Brain Res Rev       Date:  2007-08-21

2.  Autonomous initiation and propagation of action potentials in neurons of the subthalamic nucleus.

Authors:  Jeremy F Atherton; David L Wokosin; Sankari Ramanathan; Mark D Bevan
Journal:  J Physiol       Date:  2008-10-02       Impact factor: 5.182

3.  Dynamical responses to external stimuli for both cases of excitatory and inhibitory synchronization in a complex neuronal network.

Authors:  Sang-Yoon Kim; Woochang Lim
Journal:  Cogn Neurodyn       Date:  2017-06-10       Impact factor: 5.082

4.  A Selective Phosphodiesterase 10A Inhibitor Reduces L-Dopa-Induced Dyskinesias in Parkinsonian Monkeys.

Authors:  Goichi Beck; Shunsuke Maehara; Phat Ly Chang; Stella M Papa
Journal:  Mov Disord       Date:  2018-03-06       Impact factor: 10.338

5.  D2-like dopamine receptor-mediated modulation of activity-dependent plasticity at GABAergic synapses in the subthalamic nucleus.

Authors:  Jérôme Baufreton; Mark D Bevan
Journal:  J Physiol       Date:  2008-02-21       Impact factor: 5.182

6.  Sparse but selective and potent synaptic transmission from the globus pallidus to the subthalamic nucleus.

Authors:  Jérôme Baufreton; Erin Kirkham; Jeremy F Atherton; Ariane Menard; Peter J Magill; J Paul Bolam; Mark D Bevan
Journal:  J Neurophysiol       Date:  2009-05-20       Impact factor: 2.714

7.  Stimulation-Induced Transient Nonmotor Psychiatric Symptoms following Subthalamic Deep Brain Stimulation in Patients with Parkinson's Disease: Association with Clinical Outcomes and Neuroanatomical Correlates.

Authors:  Osama A Abulseoud; Aimen Kasasbeh; Hoon-Ki Min; Julie A Fields; Susannah J Tye; Stephan Goerss; Emily J Knight; Shirlene M Sampson; Bryan T Klassen; Joseph Y Matsumoto; Cynthia Stoppel; Kendall H Lee; Mark A Frye
Journal:  Stereotact Funct Neurosurg       Date:  2016-04-20       Impact factor: 1.875

Review 8.  Preconditioning as a potential strategy for the prevention of Parkinson's disease.

Authors:  Mojtaba Golpich; Behrouz Rahmani; Norlinah Mohamed Ibrahim; Leila Dargahi; Zahurin Mohamed; Azman Ali Raymond; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2014-04-03       Impact factor: 5.590

Review 9.  Sialorrhoea and drooling in patients with Parkinson's disease: epidemiology and management.

Authors:  Marcelo Merello
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  A neurochemical closed-loop controller for deep brain stimulation: toward individualized smart neuromodulation therapies.

Authors:  Peter J Grahn; Grant W Mallory; Obaid U Khurram; B Michael Berry; Jan T Hachmann; Allan J Bieber; Kevin E Bennet; Hoon-Ki Min; Su-Youne Chang; Kendall H Lee; J L Lujan
Journal:  Front Neurosci       Date:  2014-06-25       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.